New diabetes drug may help prevent lung cancer in retirement living seniors

As retirement living seniors age, their risk for diabetes increases. While the illness is serious, a new study has shown that there may be some unforeseen benefits in taking a specific diabetes medication.


Researchers have stated that Metformin, a drug widely used to treat type two diabetes, may help guard against lung cancer.

A number of studies were performed on mice, and the findings may be used to further more research.


"This well-tolerated, FDA-approved diabetes drug was able to prevent tobacco carcinogen-induced lung tumors," said Dr Phillip A. Dennis of the U.S. National Cancer Institute.


The study was conducted over the course of 13 weeks and yielded a reduction of tumors of up to 72 percent in the laboratory mice.


The effects of lung cancer are undoubtedly staggering. According to the Center for Disease Control and Prevention, more people die from the ailment than any other form of cancer.


Retirement living seniors can do their best to prevent lung cancer by staying active, eating healthy and refraining from smoking.




© Copyright